Tap to start →
Photo: Vitaly Gariev / Unsplash
1 / 3
Retatrutide is an investigational weekly injection from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon. It is not FDA-approved.
2 / 3
Retatrutide is called a triple agonist .
3 / 3
Retatrutide is the most-searched pipeline drug, and much of what is sold under its name today is unapproved.
Retatrutide is an investigational weekly injection from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon. It is not FDA-approved.
Tap below for the full page. Not medical advice; talk to your clinician about your care.